Search for a report

AUSTRALIA & NEW ZEALAND CRISPR MARKET FORECAST 2021-2026

  • You are here:
  • Home
  • Downloads
  • AUSTRALIA & NEW ZEALAND CRISPR MARKET FORECAST 2021-2026

AUSTRALIA & NEW ZEALAND CRISPR MARKET FORECAST 2021-2026

The Australia & New Zealand CRISPR market is set to project a CAGR of 21.73% during the forecast period, 2021-2026. New Zealand is an export-led economy. The plant-based primary commodities obtained from forestry, horticultural, and pastoral sectors make for half of the export earnings. Also, it is one of the few countries with regulatory status clearance for gene editing.

AUSTRALIA & NEW ZEALAND CRISPR MARKET FORECAST 2021-2026

Australia & New Zealand CRISPR Market by Product (Plasmids, Vectors, Proteins, Designing Tools, Grna, Control Kits, Library, Other Products) Market by Application (Genome Editing/genetic Engineering, CRISPR Plasmid, Human Stem Cells, Grna Database/gene Library, Cell Line Engineering) Market by End-user (Therapeutics and Drug Discovery, Biological Research, Agricultural Biotech, Industrial Biotech) by Geography

Request free sample

The Australia & New Zealand CRISPR market is set to project a CAGR of 21.73% during the forecast period, 2021-2026. New Zealand is an export-led economy. The plant-based primary commodities obtained from forestry, horticultural, and pastoral sectors make for half of the export earnings. Also, it is one of the few countries with regulatory status clearance for gene editing.australia-and-new-zealand-crispr-marketTo learn more about this report, request a free sample copy

In Australia, the Research Involving Human Embryos Act 2002 (Cth) and the Prohibition of Human Cloning for Reproduction Act 2002 (Cth) regulate the utilization of genome editing in human embryos. Earlier, the use of CRISPR in terms of gene-editing embryonic cells led to vast criticism resulting in calls for a ban internationally. The fast-paced development of genome editing resulted in the review of regulatory frameworks.  As a result, as of April 2019, the government will not regulate the use of gene-editing in animals, humans, and animal cell lines that do not introduce new genetic material. Moreover, the amendments also entail increasing the monitoring of gene-drive experiments. Genetic modifications are disseminated over an entire population, for instance, producing sterile mosquitos.

Integrated DNA Technologies (IDT) manufactures, develops, and markets nucleic acid products for the life sciences industry in pharmaceutical development, medical diagnostics, agriculture, biotechnology, and academic research areas. In addition, it is vastly recognized as the industry leader in custom nucleic acid manufacture, headquartered in Coralville, Iowa, United States.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      • IMPACT OF COVID-19 ON AUSTRALIA & NEW ZEALAND CRISPR MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • KEY BUYING CRITERIA
        • COST
        • ACCURACY
        • EASY TO USE
      • LEGAL & REGULATORY FRAMEWORK
    4. MARKET BY PRODUCT
      • PLASMIDS
      • VECTORS
      • PROTEINS
      • DESIGNING TOOLS
      • GRNA
      • CONTROL KITS
      • LIBRARY
      • OTHER PRODUCTS
    5. MARKET BY APPLICATION
      • GENOME EDITING/GENETIC ENGINEERING
      • CRISPR PLASMID
      • HUMAN STEM CELLS
      • GRNA DATABASE/GENE LIBRARY
      • CELL LINE ENGINEERING
    6. MARKET BY END-USER
      • THERAPEUTICS AND DRUG DISCOVERY
      • BIOLOGICAL RESEARCH
      • AGRICULTURAL BIOTECH
      • INDUSTRIAL BIOTECH
    7. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • GARVAN INSTITUTE OF MEDICAL RESEARCH
        • INTEGRATED DNA TECHNOLOGIES
        • MILLENIUM SCIENCE
        • MILLIPORESIGMA
        • NEW ENGLAND BIOLABS

    LIST OF TABLES  

    TABLE 1: MARKET SNAPSHOT – CRISPR

    TABLE 2: REGULATORY FRAMEWORK

    TABLE 3: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 4: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 5: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 6: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 7: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 8: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 9: LIST OF MERGERS & ACQUISITIONS

    TABLE 10: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 11: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 12: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

    LIST OF FIGURES 

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: KEY BUYING CRITERIA

    FIGURE 5: AUSTRALIA & NEW ZEALAND CRISPR MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020

    FIGURE 6: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY PLASMIDS, 2021-2026 (IN $ MILLION)

    FIGURE 7: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY VECTORS, 2021-2026 (IN $ MILLION)

    FIGURE 8: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY PROTEINS, 2021-2026 (IN $ MILLION)

    FIGURE 9: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY DESIGNING TOOLS, 2021-2026 (IN $ MILLION)

    FIGURE 10: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY GRNA, 2021-2026 (IN $ MILLION)

    FIGURE 11: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY CONTROL KITS, 2021-2026 (IN $ MILLION)

    FIGURE 12: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY LIBRARY, 2021-2026 (IN $ MILLION)

    FIGURE 13: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY OTHER PRODUCTS, 2021-2026 (IN $ MILLION)

    FIGURE 14: AUSTRALIA & NEW ZEALAND CRISPR MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

    FIGURE 15: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2026 (IN $ MILLION)

    FIGURE 16: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY CRISPR PLASMID, 2021-2026 (IN $ MILLION)

    FIGURE 17: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2026 (IN $ MILLION)

    FIGURE 18: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2026 (IN $ MILLION)

    FIGURE 19: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2026 (IN $ MILLION)

    FIGURE 20: AUSTRALIA & NEW ZEALAND CRISPR MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 21: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY THERAPEUTICS AND DRUGS DISCOVERY, 2021-2026 (IN $ MILLION)

    FIGURE 22: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2026 (IN $ MILLION)

    FIGURE 23: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2026 (IN $ MILLION)

    FIGURE 24: AUSTRALIA & NEW ZEALAND CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2026 (IN $ MILLION)

    1. MARKET BY PRODUCT
      • PLASMIDS
      • VECTORS
      • PROTEINS
      • DESIGNING TOOLS
      • GRNA
      • CONTROL KITS
      • LIBRARY
      • OTHER PRODUCTS
    2. MARKET BY APPLICATION
      • GENOME EDITING/GENETIC ENGINEERING
      • CRISPR PLASMID
      • HUMAN STEM CELLS
      • GRNA DATABASE/GENE LIBRARY
      • CELL LINE ENGINEERING
    3. MARKET BY END-USER
      • THERAPEUTICS AND DRUG DISCOVERY
      • BIOLOGICAL RESEARCH
      • AGRICULTURAL BIOTECH
      • INDUSTRIAL BIOTECH

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now